3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma
7
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Recurrence
3
Neoplasms
2
Leukemia, B-Cell
2
Burkitt Lymphoma
2
Neoplasm, Residual
1
Mature B-Cell Malignancies
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphatic Diseases
1
Leukemia, Hairy Cell
1
Heart Failure
1
Dendritic Cell Sarcoma, Interdigitating
1
Cytokine Release Syndrome
1
Interventions
Gemcitabine
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
8
Cisplatin
7
pembrolizumab
6
Radiation
5
Mitomycin
4
Fluorouracil
4
Cystoscopy
4
enfortumab vedotin
3
durvalumab
3
dehydroftorafur
3
avelumab
3
Transurethral Resection of Bladder
3
Radiotherapy
3
Platinum
3
Nivolumab
3
Mitozytrex
3
Cystectomy
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
tremelimumab
2
erdafitinib
2
atezolizumab
2
Paclitaxel
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
Carboplatin
2
Biopsy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
obinutuzumab
×
30 days
×
Clear all
No trials found.